Journal
JOURNAL OF CANCER
Volume 9, Issue 2, Pages 219-231Publisher
IVYSPRING INT PUBL
DOI: 10.7150/jca.22554
Keywords
Breast cancer; tumorigenesis; metastasis; mutations; transcription; protein degradation; anticancer resistance; CRISPR/Cas9; genome
Categories
Ask authors/readers for more resources
Breast cancer is the leading diagnosed cancer for women globally. Evolution of breast cancer in tumorigenesis, metastasis and treatment resistance appears to be driven by the aberrant gene expression and protein degradation encoded by the cancer genomes. The uncontrolled cancer growth relies on these cellular events, thus constituting the cancerous programs and rendering the addiction towards them. These programs are likely the potential anticancer biomarkers for Personalized Medicine of breast cancer. This review intends to delineate the impact of the CRSPR/Cas-mediated genome editing in identification and validation of these anticancer biomarkers. It reviews the progress in three aspects of CRISPR/Cas9-mediated editing of the breast cancer genomes: Somatic genome editing, transcription and protein degradation addictions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available